February 8, 2024Open Access

Ashwagandha

XLXin Yi LimMinistry of Health JBJoanne BarnesUniversity of Auckland

Key Points

Key points are not available for this paper at this time.

Abstract

© 2024 Os Autor(es) (ou seu(s) empregador(es)). Publicado pela CSIRO Publishing em nome do Royal New Zealand College of General Practitioners. Este é um artigo de acesso aberto distribuído sob a Licença Internacional Creative Commons Atribuição-NãoComercial-SemDerivações 4.0 (CC BY-NC-ND)

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Lim et al. (Qui,) estudaram essa questão.

synapsesocial.com/papers/68e7b7dcb6db64358770e626 https://doi.org/https://doi.org/10.1071/hc23172

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda2020 · 155 citations
2Ashwagandha (Withania somnifera) for the treatment and enhancement of mental and physical conditions: A systematic review of human trials2021 · 57 citations
3Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta‐analysis of randomized controlled trials2022 · 71 citations
4Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study2019 · 120 citations
5Adjunctive Use of a Standardized Extract of <em>Withania somnifera</em> (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia2018 · 72 citations

Perguntar à IA

Bookmark

View Full Paper